A mix of negatives weighed on FMC’s profitability. The re-occurrence of the pandemic proved costly as the number of isolation clinics had to be re-ramped and the labour shortage resulted in higher wages. In addition, excess deaths increased despite high vaccination rates. Higher input costs were added to the mix making it a perfect storm.
Consensus was slightly beaten at the top-line (+1.2%), whereas the EBIT line came in slightly above (+1.8%) street expectations.

04 May 2022
A slightly infected start to 2022

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
A slightly infected start to 2022
Fresenius Medical Care AG (FME:ETR) | 0 0 0.0%
- Published:
04 May 2022 -
Author:
Martin Schnee -
Pages:
4 -
A mix of negatives weighed on FMC’s profitability. The re-occurrence of the pandemic proved costly as the number of isolation clinics had to be re-ramped and the labour shortage resulted in higher wages. In addition, excess deaths increased despite high vaccination rates. Higher input costs were added to the mix making it a perfect storm.
Consensus was slightly beaten at the top-line (+1.2%), whereas the EBIT line came in slightly above (+1.8%) street expectations.